title: The effect of estrogen on prolidase-dependent regulation of HIF-1α expression in breast cancer cells.
abstract: The role of estrogen in breast cancer progression and activation of prolidase activity and HIF-1α led us to study the effect of estrogen on nuclear HIF-1α expression in breast cancer estrogen-dependent MCF-7 and estrogen-independent MDA-MB-231 cells. We have found that in MCF-7 cells (expressing α and β estrogen receptor) cultured without estrogen receptor activator (phenol red, estradiol), HIF-1α was down-regulated, compared to the cells cultured with estrogen receptor activator. This effect was not observed in MDA-MB-231 cells (expressing only β estrogen receptor), suggesting that α estrogen receptor is involved in down-regulation of HIF-1α. However, in MDA-MB-231 cells (expressing high prolidase activity) cultured in the presence of prolidase substrates, Gly-Pro or Gly-HyPro, HIF-1α expression was induced in a dose-dependent manner, independently of estrogen receptor activation. In MCF-7 cells (with constitutively low prolidase activity) the effect of studied iminodipeptides on HIF-1α expression was much less pronounced but it was estrogen-dependent, showing importance of prolidase activity in mechanism of this process. The data were supported by confocal microscopy bio-imaging of HIF-1α in nucleus of MCF-7 and MDA-MB-231 cells that were cultured in the presence and absence of estrogen activator and prolidase substrates. It suggests that estrogen receptor may represent important therapeutic target in pharmacotherapy of estrogen receptor positive breast cancer, while ECM degradation enzymes, including prolidase may represent target in pharmacotherapy of estrogen receptor negative breast cancers.
authors.affiliation: Department of Medicinal Chemistry, Medical University of Bialystok, Bialystok, Poland.
authors.forename: Arkadiusz
authors.initials: A
authors.lastname: Surazynski
authors.forename: Wojciech
authors.initials: W
authors.lastname: Miltyk
authors.forename: Izabela
authors.initials: I
authors.lastname: Prokop
authors.forename: Jerzy
authors.initials: J
authors.lastname: Palka
mesh_terms: D004150:Dipeptidases / Q000378:metabolism*; D004958:Estradiol / Q000494:pharmacology / Q000502:physiology; D047628:Estrogen Receptor alpha / Q000378:metabolism; D047629:Estrogen Receptor beta / Q000378:metabolism; D004967:Estrogens / Q000494:pharmacology / Q000502:physiology*; D005260:Female; D015870:Gene Expression; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D051795:Hypoxia-Inducible Factor 1, alpha Subunit / Q000235:genetics* / Q000378:metabolism; D061986:MCF-7 Cells; D009842:Oligopeptides / Q000502:physiology
chemical_list: C506487:ESR1 protein, human; D047628:Estrogen Receptor alpha; D047629:Estrogen Receptor beta; D004967:Estrogens; C497442:HIF1A protein, human; D051795:Hypoxia-Inducible Factor 1, alpha Subunit; D009842:Oligopeptides; D004958:Estradiol; D004150:Dipeptidases; C022449:proline dipeptidase
references.citation: Annu Rev Biochem. 1994;63:451-86
references.pmid: 7979245
references.citation: Anticancer Res. 1992 May-Jun;12(3):789-94
references.pmid: 1622138
references.citation: Biol Reprod. 1998 Mar;58(3):627-32
references.pmid: 9510949
references.citation: Gynecol Endocrinol. 1999 Jun;13(3):166-74
references.pmid: 10451808
references.citation: Cancer Treat Res. 1988;40:119-65
references.pmid: 2908648
references.citation: Cancer Res. 1990 Jul 15;50(14):4177-89
references.pmid: 2194650
references.citation: Cancer Res. 1990 Feb 1;50(3):717-21
references.pmid: 2297709
references.citation: Virchows Arch A Pathol Anat Histopathol. 1985;406(1):125-31
references.pmid: 3922107
references.citation: Proc Natl Acad Sci U S A. 1988 Apr;85(7):2307-10
references.pmid: 3353379
references.citation: Cancer Res. 1986 Jan;46(1):1-7
references.pmid: 2998604
references.citation: J Cell Biochem. 2005 Dec 1;96(5):1086-94
references.pmid: 16167338
references.citation: Mol Cell Biol. 2002 Aug;22(16):5835-45
references.pmid: 12138194
references.citation: Arch Dermatol. 1991 Jan;127(1):124-5
references.pmid: 1986698
references.citation: Int J Cancer. 2008 Mar 15;122(6):1435-40
references.pmid: 17999410
references.citation: Cancer. 1992 Aug 15;70(4 Suppl):977-82
references.pmid: 1638467
references.citation: Nature. 1970 Aug 15;227(5259):680-5
references.pmid: 5432063
references.citation: J Biol Chem. 1982 Oct 25;257(20):12252-6
references.pmid: 7118942
references.citation: Int J Mol Med. 2003 Nov;12(5):803-9
references.pmid: 14533013
references.citation: Cancer Res. 1985 Feb;45(2):584-90
references.pmid: 3967234
references.citation: J Natl Cancer Inst. 1992 Feb 19;84(4):231-4
references.pmid: 1346404
references.citation: Clin Chim Acta. 1982 Oct 27;125(2):193-205
references.pmid: 7139961
references.citation: Amino Acids. 2008 Nov;35(4):731-8
references.pmid: 18320291
references.citation: Eur J Pharmacol. 2010 Dec 15;649(1-3):115-9
references.pmid: 20868675
references.citation: Br J Cancer. 1988 Feb;57(2):205-12
references.pmid: 3358913